Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia

British Journal of Cancer

Volumn 78, Issue 6, 1998, Pages 752-756

  Thews, O ^a   Koenig, R ^a   Kelleher, D K ^a   Kutzner, J ^a   Vaupel, P ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Anaemia; Carboplatin; Epoetin beta; Erythropoietin; Radiosensitivity

Indexed keywords

CARBOPLATIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; FOOT; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; RAT; SOLID TUMOR;

EID: 0031658227     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.572     Document Type: Article

References (22)

1. Bush RS, Jenkin RDT, Allt WEC, Beale FA, Dembo AJ and Pringle JF (1978) Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 37 (suppl. 3): 302-306
2. Busse M and Vaupel PW (1995) The role of tumor volume in 'reoxygenation' upon cyclophosphamide treatment. Acta Oncol 34: 405-408
3. de Campos E, Radford J, Steward W, Milroy R, Dougal M, Swindell R, Testa N and Thatcher N (1995) Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer. J Clin Oncol 13: 1623-1631
4. Grau C and Overgaard J (1998) Significance of hemoglobin concentration for treatment outcome. In Blood Perfusion and Microenvironment of Human Tumors Implications for Clinical Radiology. Molls M and Vaupel P (eds), pp. 101-112. Springer-Verlag Berlin
5. Hewitt HB and Blake ER (1971) Effect of induced host anaemia on the viability and radiosensitivity of murine malignant cells in vivo. Br J Cancer 25: 322-336
6. Hill RP, Bush RS and Yeung P (1972) The effect of anemia on the fraction of hypoxic cells in an experimental tumor. Br J Radiol 44: 299-304
7. Hirst DG, Hazelhurst JL and Brown JM (1984) The effect of alterations in hematocrit on tumor sensitivity to X-rays. Int J Radiat Biol 46: 345-354
8. Joiner B, Hirst VK, McKeown SR, McAleer JJA and Hirst DG (1993) The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse. Br J Cancer 68: 720-726
9. Kelleher DK, Matthiensen U, Thews O and Vaupel P (1995) Tumor oxygenation in anemic rats effects of erythropoietin treatment versus red blood cell transfusion. Acta Oncol 34: 379-384
10. Kelleher DK, Matthiensen U, Thews O and Vaupel P (1996) Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats. Cancer Res 56: 4728-4734
11. Lavey RS and Dempsey WH (1993) Erythropoietin increases hemoglobin in cancer patients during radiation therapy. Int J Radiat Oncol Biol Phys 27: 1147-1152
12. Levine EA and Vijayakumar S (1993) Blood transfusion in patients receiving radical radiotherapy: a reappraisal. Onkologie 16: 79-87
13. Markman M, Reichman B, Hakes T, Rubin S, Jones W, Lewis JL, Barakat R, Curtin J, Almadrones L and Hoskins W (1993) The use of recombinant human erythropoietin to prevent carboplatin-induced anemia. Gynecol Oncol 49: 172-176
14. McCormack M, Nais AHW and Smith E (1990) Chronic anaemia, hyperbaric oxygen and tumour radiosensitivity. Br J Radiol 63: 752-759
15. Ohno S, Strebel FR, Stephens LC, Siddik ZH, Baba H, Makino M, Khokhar AR and Bull JMC (1993) Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats. Br J Cancer 68: 469-474
16. Reece PA, Bishop JF, Olver IN, Stafford I, Hillcoat BL and Morstyn G (1987) Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma. Cancer Chemother Pharmacol 19: 326-330
17. Rojas A, Stewart FA, Smith KA, Soranson JA, Randhawa VS, Stratford MRL and Denekamp J (1987) Effect of anemia on tumor radiosensitivity under normo and hyperbaric conditions. Int J Radiat Oncol Biol Phys 13: 1681-1689
18. Siddik ZH, Boxall FE and Harrap KR (1987) Haematological toxicity of carboplatin in rats. Br J Cancer 55: 375-379
19. Spivak JL (1994) Recombinant human erythropoietin and the anemia of cancer. Blood 84: 997-1004
20. Tannock IF and Steel GG (1970) Tumor growth and cell kinetics in chronically hypoxic animals. J Natl Cancer Inst 45: 123-133
21. Vaupel P, Kallinowski F and Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465
22. Vijayakumar S, Roach M, Wara W, Chan SK, Ewing C, Rubin S, Sutton H, Halpern H, Awan A, Houghton A, Quiet C and Weichselbaum R (1993) Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial. Int J Radiat Oncol Biol 26: 721-729